Welcome to the Czech-Norwegian joint project focused on discovering specific mitophagy biomarkers.

The Mit-AD project aims to develop early diagnostic biomarkers of Alzheimer’s disease (AD) by validating a series of new biomarkers in serum and cerebrospinal fluid (CSF) in participants from the Czech Brain Aging Study (CBAS). This Czech–Norwegian joint project will involve researchers from CBAS – Czech team with a unique clinical cohort and a top Norwegian research team specialized in mitophagy research.

  • From: Culprit of Bystander: Defective Mitophagy in Alzheimer’s Disease (Xie et al. 2020, Front. Cell Dev. Biol.)

The Validation of specific mitophagy biomarkers across Alzheimer’s disease continuum benefits from a € 1 404 000 grant from Iceland, Liechtenstein and Norway through the EEA Grants and the Technology Agency of the Czech Republic within the KAPPA Programme.